Critical Review of Prasugrel for Formulary Decision Makers

por Schafer, Jeremy
Publicado 2009

Opportunities and Challenges of Value-Based Health Care: How Brazil Can Learn from U.S. Experience

por Abicalaffe, César, Schafer, Jeremy
Publicado 2020

Formulary Management of the Protease Inhibitors Boceprevir and Telaprevir for Chronic Hepatitis C Virus

por Tungol, Alexandra, Rademacher, Kellie, Schafer, Jeremy A.
Publicado 2011

Formulary Review of 2 New Biologic Agents: Tocilizumab for Rheumatoid Arthritis and Ustekinumab for Plaque Psoriasis

por Schafer, Jeremy A., Kjesbo, Nicole K., Gleason, Patrick P.
Publicado 2010

Price Increases and New Drugs Drive Increased Expenditures for Multiple Sclerosis

por Schafer, Jeremy A., Gunderson, Brent W., Gleason, Patrick P.
Publicado 2010

Telithromycin: The Perils of Hasty Adoption and Persistence of Off-Label Prescribing

por Gleason, Patrick P., Walters, Carol, Heaton, Alan H., Schafer, Jeremy A.
Publicado 2007

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events

por Starner, Catherine I., Schafer, Jeremy A., Heaton, Alan H., Gleason, Patrick P.
Publicado 2008

Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications

por Gleason, Patrick, Starner, Catherine I., Gunderson, Brent W., Schafer, Jeremy A., Sarran, H. Scott
Publicado 2009

Generic Drug Discount Programs: Are Prescriptions Being Submitted for Pharmacy Benefit Adjudication?

por Tungol, Alexandra, Starner, Catherine I., Gunderson, Brent W., Schafer, Jeremy A., Qiu, Yang, Gleason, Patrick P.
Publicado 2012